8-K/A

AMENDMENT NO. 4 TO FORM 8-K

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: February 6, 2012
Period of Report: January 31, 2012
Accession Number: 0001144204-12-005892

View Document ↗ View on SEC.gov ↗